Abstract:Amycolatopsis sp. strain TNS106 harbors a ristomycin-biosynthetic gene cluster (asr) in its genome and produces ristomycin A. Deletion of the sole cluster-situated StrR family regulatory gene, asrR, abolished ristomycin A production and the transcription of the asr genes orf5 to orf39. The ristomycin A fermentation titer in Amycolatopsis sp. strain TNS106 was dramatically improved by overexpression of asrR and a heterologous StrR family regulatory gene, bbr, from the balhimycin-biosynthetic gene cluster (BGC) utilizing strong promoters and multiple gene copies. Ristomycin A production was improved by approximately 60-fold, resulting in a fermentation titer of 4.01 g/liter in flask culture, in one of the engineered strains. Overexpression of AsrR and Bbr upregulated transcription of tested asr biosynthetic genes, indicating that these asr genes were positively regulated by AsrR and Bbr. However, only the promoter region of the asrR operon and the intergenic region upstream of orf12 were bound by AsrR and Bbr in gel retardation assays, suggesting that AsrR and Bbr directly regulated the asrR operon and probably orf12 to orf14 but no other asr biosynthetic genes. Further assays with synthetic short probes showed that AsrR and Bbr specifically bound not only probes containing the canonical inverted repeats but also a probe with only one 7-bp element of the inverted repeats in its native context. AsrR and Bbr have an N-terminal ParB-like domain and a central winged helix-turn-helix DNA-binding domain. Site-directed mutations indicated that the N-terminal ParB-like domain was involved in activation of ristomycin A biosynthesis and did not affect the DNA-binding activity of AsrR and Bbr. IMPORTANCE This study showed that overexpression of either a native StrR family regulator (AsrR) or a heterologous StrR family regulator (Bbr) dramatically improved ristomycin A production by increasing the transcription of biosynthetic genes directly or indirectly. The conserved ParB-like domain of AsrR and Bbr was demonstrated to be involved in the regulation of asr BGC expression. These findings provide new insights into the mechanism of StrR family regulators in the regulation of glycopeptide antibiotic biosynthesis. Furthermore, the regulator overexpression plasmids constructed in this study could serve as valuable tools for strain improvement and genome mining for new glycopeptide antibiotics. In addition, ristomycin A is a type III glycopeptide antibiotic clinically used as a diagnostic reagent due to its side effects. The overproduction strains engineered in this study are ideal materials for industrial production of ristomycin A.

Function of Orf1*c Gene Biosynthesizing Spiramycin Produced by Streptomyces Ambofaciens and Strain Improvement

Characterization of an Lrp/AsnC Family Regulator SCO3361, Controlling Actinorhodin Production and Morphological Development in Streptomyces Coelicolor.

A Single-Domain Small Protein Med-Orf10 Regulates The Production Of Antitumour Agent Medermycin In Streptomyces

A S-adenosylmethionine Dependent Methyltransferase Homologous Gene,sco1162,Regulates Spore Development and Antibiotic Synthesis in Streptomyces Coelicolor

Identification of A Gene Negatively Affecting Antibiotic Production and Morphological Differentiation in Streptomyces Coelicolor A3(2)

Enhancing Ristomycin A Production by Overexpression of ParB-Like StrR Family Regulators Controlling the Biosynthesis Genes

Increased expression of ribosome recycling factor is responsible for the enhanced protein synthesis during the late growth phase in an antibiotic-overproducing Streptomyces coelicolor ribosomal rpsL mutant.

Novel Mutations in the Ribosomal L11 Protein Gene (rplkrelc) of Streptomyces Coelicolor A3(2).

Transcriptomic analysis of a spiramycin I-resistant Staphylococcus aureus mutant

ActVI-ORFA directs metabolic flux towards actinorhodin by preventing intermediate degradation

Sulfane sulfur‐activated actinorhodin production and sporulation is maintained by a natural gene circuit in Streptomyces coelicolor

Heterologous expression of the biosynthetic gene cluster of pamamycin and investigation on the functions of regulatory genes from Streptomyces lincolnensis NRRL 2936

Enhancing Macrolide Production in Streptomyces by Coexpressing Three Heterologous Genes.

Elimination of Indigenous Linear Plasmids in Streptomyces Hygroscopicus Var. Jinggangensis and Streptomyces Sp. FR008 to Increase Validamycin A and Candicidin Productivities.

Deletion of the hypothetical protein SCO2127 of Streptomyces coelicolor allowed identification of a new regulator of actinorhodin production

Characterization of LnmO as a pathway-specific Crp/Fnr-type positive regulator for leinamycin biosynthesis in Streptomyces atroolivaceus and its application for titer improvement

Improving the production of carbamoyltobramycin by an industrial Streptoalloteichus tenebrarius through metabolic engineering

Co-expression of a SARP Family Activator ChlF2 and a Type II Thioesterase ChlK Led to High Production of Chlorothricin in Streptomyces antibioticus DSM 40725

[Disruption of Zwf2 Gene to Improve Oxytetraclyline Biosynthesis in Streptomyces Rimosus M4018].

Characterization and engineering of the Lrp/AsnC family regulator SACE_5717 for erythromycin overproduction in Saccharopolyspora erythraea

Engineering of the LysR Family Transcriptional Regulator FkbR1 and Its Target Gene to Improve Ascomycin Production